Peter Kozuch

1.4k total citations
42 papers, 1.1k citations indexed

About

Peter Kozuch is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Peter Kozuch has authored 42 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Oncology, 15 papers in Pulmonary and Respiratory Medicine and 8 papers in Surgery. Recurrent topics in Peter Kozuch's work include Colorectal Cancer Treatments and Studies (15 papers), Pancreatic and Hepatic Oncology Research (15 papers) and Cancer Treatment and Pharmacology (9 papers). Peter Kozuch is often cited by papers focused on Colorectal Cancer Treatments and Studies (15 papers), Pancreatic and Hepatic Oncology Research (15 papers) and Cancer Treatment and Pharmacology (9 papers). Peter Kozuch collaborates with scholars based in United States, Guatemala and Poland. Peter Kozuch's co-authors include Michael L. Grossbard, Michael Chung, F. G. Kamar, Kevin M. Sullivan, Hagop M. Kantarjian, Peter R. Holt, Mary Beth Rios, Howard W. Bruckner, Francis J. Giles and Jörge E. Cortes and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and European Journal of Cancer.

In The Last Decade

Peter Kozuch

40 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Kozuch United States 19 557 263 259 255 176 42 1.1k
Carlyn Tan United States 15 533 1.0× 424 1.6× 289 1.1× 209 0.8× 170 1.0× 60 1.3k
Abdurrahman Işıkdoğan Türkiye 19 537 1.0× 424 1.6× 204 0.8× 204 0.8× 75 0.4× 146 1.2k
Hun Mo Ryoo South Korea 17 371 0.7× 148 0.6× 237 0.9× 113 0.4× 336 1.9× 47 930
Yunsuk Choi South Korea 18 444 0.8× 258 1.0× 339 1.3× 90 0.4× 480 2.7× 101 1.1k
Ta‐Chung Chao Taiwan 22 724 1.3× 485 1.8× 317 1.2× 139 0.5× 85 0.5× 99 1.4k
Silvia Brugnatelli Italy 22 635 1.1× 219 0.8× 531 2.1× 169 0.7× 338 1.9× 78 1.4k
Po‐Min Chen Taiwan 17 461 0.8× 104 0.4× 359 1.4× 152 0.6× 265 1.5× 80 1.2k
Yeşim Eralp Türkiye 21 555 1.0× 279 1.1× 186 0.7× 198 0.8× 72 0.4× 94 1.3k
Donna E. Levy United States 15 483 0.9× 324 1.2× 256 1.0× 109 0.4× 232 1.3× 24 1.5k
J J Shuster United States 25 334 0.6× 245 0.9× 340 1.3× 181 0.7× 288 1.6× 34 1.6k

Countries citing papers authored by Peter Kozuch

Since Specialization
Citations

This map shows the geographic impact of Peter Kozuch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Kozuch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Kozuch more than expected).

Fields of papers citing papers by Peter Kozuch

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Kozuch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Kozuch. The network helps show where Peter Kozuch may publish in the future.

Co-authorship network of co-authors of Peter Kozuch

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Kozuch. A scholar is included among the top collaborators of Peter Kozuch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Kozuch. Peter Kozuch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Kozuch, Peter, et al.. (2017). Metformin as a repurposed therapy in advanced non-small cell lung cancer (NSCLC): results of a phase II trial. Investigational New Drugs. 35(6). 813–819. 48 indexed citations
3.
Shukla, Pratik A., et al.. (2015). Gastric Perforation Following Prophylactic Embolization of Right Gastric and Gastroduodenal Arteries Prior to Selective Internal Radiation Therapy. CardioVascular and Interventional Radiology. 38(6). 1645–1648.
4.
Yamaguchi, Norihiro, Takeo Fujii, Shunsuke Aoi, et al.. (2015). Comparison of cardiac events associated with liposomal doxorubicin, epirubicin and doxorubicin in breast cancer: a Bayesian network meta-analysis. European Journal of Cancer. 51(16). 2314–2320. 64 indexed citations
7.
Sullivan, Kevin M. & Peter Kozuch. (2012). Chemotherapy and Other Supportive Modalities in the Palliative Setting for Pancreatic Cancer. The Cancer Journal. 18(6). 633–641. 5 indexed citations
8.
Olszewski, Adam J., Michael L. Grossbard, Michael Chung, et al.. (2012). Phase I Study of Oxaliplatin in Combination with Gemcitabine, Irinotecan, and 5-Fluorouracil/Leucovorin (G-FLIE) in Patients with Metastatic Solid Tumors Including Adenocarcinoma of the Pancreas. Journal of Gastrointestinal Cancer. 44(2). 182–189. 2 indexed citations
9.
Kozuch, Peter, et al.. (2011). Case Report: Long-Term Survival in Patients with Initial Lung-Only Metastasis from Pancreatic Adenocarcinoma. Journal of Gastrointestinal Cancer. 43(S1). 50–55. 4 indexed citations
10.
Kozuch, Peter, et al.. (2009). Phase II Trial of Erlotinib and Capecitabine for Patients with Previously Untreated Metastatic Colorectal Cancer. Clinical Colorectal Cancer. 8(1). 38–42. 11 indexed citations
11.
Holt, Peter R., et al.. (2009). Colon cancer and the elderly: From screening to treatment in management of GI disease in the elderly. Best Practice & Research Clinical Gastroenterology. 23(6). 889–907. 42 indexed citations
13.
Kamar, F. G., et al.. (2004). Pancreatic carcinoma with brain metastases: case report and literature review. Digestive and Liver Disease. 36(5). 355–360. 25 indexed citations
14.
Grossbard, Michael L., et al.. (2004). Gallbladder and biliary tract carcinoma: A comprehensive update, Part 2.. PubMed. 18(8). 1049–59; discussion 1060, 1065. 61 indexed citations
15.
Bruckner, Howard W., Michael L. Grossbard, David Frager, et al.. (2003). Biweekly Low-dose Sequential Gemcitabine, 5-Fluorouracil, Leucovorin, And Cisplatin (Gfp): A Highly Active Novel Therapy For Metastatic Adenocarcinoma Of The Exocrine Pancreas. Cancer Investigation. 21(4). 489–496. 12 indexed citations
16.
Kozuch, Peter, et al.. (2002). A comprehensive update on the use of chemotherapy for metastatic pancreatic adenocarcinoma. Hematology/Oncology Clinics of North America. 16(1). 123–138. 6 indexed citations
17.
Kozuch, Peter, et al.. (2001). TREATMENT OF METASTATIC PANCREATIC ADENOCARCINOMA. Surgical Clinics of North America. 81(3). 683–690. 5 indexed citations
18.
Kantarjian, Hagop M., Jianqin Shan, Terry Smith, et al.. (2001). Response to therapy is independently associated with survival prolongation in chronic myelogenous leukemia in the blastic phase. Cancer. 92(10). 2501–2507. 17 indexed citations
19.
Kozuch, Peter, et al.. (2001). THERAPY FOR REGIONALLY UNRESECTABLE PANCREATIC CANCER. Surgical Clinics of North America. 81(3). 691–697. 3 indexed citations
20.
Kozuch, Peter, et al.. (2000). Avascular necrosis of the femoral head in chronic myeloid leukemia patients treated with interferon-?. Cancer. 89(7). 1482–1489. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026